DDICX
Price
$16.09
Change
+$0.06 (+0.37%)
Updated
Oct 17 closing price
Net Assets
836.81M
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

DDICX vs RLBCX

Header iconDDICX vs RLBCX Comparison
Open Charts DDICX vs RLBCXBanner chart's image
Macquarie Wealth Builder C
Price$16.09
Change+$0.06 (+0.37%)
VolumeN/A
Net Assets836.81M
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
DDICX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
DDICX vs. RLBCX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDICX is a Hold and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. DDICX (837M). RLBCX pays higher dividends than DDICX: RLBCX (1.49) vs DDICX (0.82). DDICX was incepted earlier than RLBCX: DDICX (22 years) vs RLBCX (23 years). DDICX (1.84) is less costly to investors than RLBCX (0.89). DDICX is a more actively managed with annual turnover of: 66.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than DDICX: RLBCX (250) vs DDICX (1000). RLBCX annual gain was more profitable for investors over the last year : 8.34 vs. DDICX (2.64). RLBCX return over 5 years is better than : 40.24 vs. DDICX (27.49).
DDICXRLBCXDDICX / RLBCX
Total Expense Ratio1.810.89203%
Annual Report Gross Expense Ratio1.840.89207%
Fund Existence22 years23 years-
Gain YTD9.73314.36468%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets837M265B0%
Annual Yield % from dividends0.821.4955%
Returns for 1 year2.648.3432%
Returns for 3 years24.5449.2650%
Returns for 5 years27.4940.2468%
Returns for 10 years34.4172.1848%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBM3.520.07
+2.03%
Psyence Biomedical Ltd
CVGW23.810.14
+0.59%
Calavo Growers
SWK67.85-0.06
-0.09%
Stanley Black & Decker
IQ2.03-0.03
-1.46%
iQIYI
PMVP1.40-0.04
-2.78%
PMV Pharmaceuticals